A possible H5N1 vaccine A vaccine against the most deadliest and common strain of avian flu.

A possible H5N1 vaccine A vaccine against the most deadliest and common strain of avian flu, H5N1, has been engineered and tested by researchers at the University of Pittsburgh’s Middle for Vaccine Research and Novavax Inc. Relating to a scholarly research published by the Public Library of Science in the Jan. 30 issue of PLoS ONE, the vaccine produced a solid immune response in mice and covered them from death following infection with the H5N1 virus levitra precio farmacia . The vaccine is being tested in humans within an early-phase clinical trial. Recent outbreaks of avian flu all over the world possess prompted wellness officials to warn of its continued threat to global health insurance and potential to trigger a flu pandemic.